Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
Genelux Corporation
Genelux Corporation
Akeso
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Incyte Corporation
Ipsen
Hoffmann-La Roche
DualityBio Inc.
AstraZeneca
Arcus Biosciences, Inc.
Merck Sharp & Dohme LLC
AstraZeneca
Novartis
Merck Sharp & Dohme LLC
Gilead Sciences
AstraZeneca
Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.
Hoffmann-La Roche
Merck Sharp & Dohme LLC
Hoffmann-La Roche
Revolution Medicines, Inc.
Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.
RenovoRx
Merck Sharp & Dohme LLC
ImmunityBio, Inc.
Daiichi Sankyo
Gilead Sciences
Qilu Pharmaceutical Co., Ltd.
Merck Sharp & Dohme LLC
Gilead Sciences
Corcept Therapeutics
Biotheus Inc.
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Jiangsu HengRui Medicine Co., Ltd.
Sumitomo Pharma America, Inc.
Hoffmann-La Roche
Novartis
Celgene
Jiangsu HengRui Medicine Co., Ltd.
Nektar Therapeutics
ERYtech Pharma
Hoffmann-La Roche
Hoffmann-La Roche
Hoffmann-La Roche
Hoffmann-La Roche